Physician profile
Daniel S Thomas
NPI 1871768671
$5,354.86
in general payments reported to CMS, 2019-2025
29 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $2,081 · 2021: $815 · 2022: $1,159 · 2023: $324 · 2024: $183 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.31 |
| Education | $122.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,495.30 | 2020-2025 | Proclaim, Eterna |
| Pacira Pharmaceuticals Incorporated | $705.77 | 2022-2023 | Iovera, Zilretta, Exparel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $520.92 | 2019-2025 | Relistor |
| Spr Therapeutics, INC | $199.63 | 2020-2021 | |
| Boston Scientific Corporation | $189.90 | 2020-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $170.11 | 2019-2024 | Mild Device Kit |
| Medtronic USA, INC. | $167.75 | 2019-2020 | |
| Nevro Corp. | $126.03 | 2020-2024 | Senza |
| Horizon Therapeutics Plc | $124.12 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $108.47 | 2021-2023 | Ztlido |
| Teva Pharmaceuticals USA, INC. | $100.65 | 2019-2020 | |
| Uswm, LLC | $44.51 | 2021 | |
| Medtronic, INC. | $37.63 | 2023 | Intellis Adaptivestim |
| Biogen, INC. | $37.37 | 2021-2022 | |
| Mdd US Operations, LLC | $34.60 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $34.56 | 2022 | |
| Redhill Biopharma INC. | $28.98 | 2021-2022 | |
| Si-Bone, INC. | $28.39 | 2019-2021 | |
| Almatica Pharma LLC | $28.38 | 2021 | |
| Pfizer INC. | $27.24 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.00 | 2025 | |
| Saluda Medical Americas, INC. | $21.80 | 2024 | Evoke |
| Forte Bio-Pharma LLC | $21.60 | 2021 | |
| Avanos Medical | $16.41 | 2024 | Generator |
| Biotronik Nro, INC. | $15.36 | 2025 | Prospera |
| Allergan, INC. | $14.04 | 2021 | |
| Radius Health, INC. | $12.08 | 2021 | |
| Grt US Holding, INC. | $11.36 | 2021 | |
| Nalu Medical, INC. | $9.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.